| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and Chairman | Director | President, CEO and Chairman
2 companies
David M Stack last filed a Form 4 in June 2023, as CEO and Chairman at PCRX. The filings on record cover 2 companies. From January 2015 to June 2023, the filings on record show 2 open-market purchases and 35 sales. David M Stack's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns David M Stack a middling insider score of 67/100, based on 9 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -1.1%.
At the last filing, the largest reported position was 186,481 shares of PCRX. The PCRX filings lean toward selling, a net 785,290 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sell | 15,000 | $47.39 | $710,801.10 | -11.0% | |
| Aug 15, 2018 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 33,062 | $47.32 | $1,564,431.94 | -26.5% | |
| Jun 7, 2018 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sell | 18,406 | $36.28 | $667,764.48 | -18.3% | |
| May 15, 2018 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 25,000 | $33.79 | $844,781.10 | -19.9% | |
| Jan 10, 2018 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 28,885 | $40.19 | $1,160,975.41 | -22.3% | |
| Nov 15, 2017 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 58,885 | $38.34 | $2,257,708.20 | -37.0% | |
| Aug 15, 2017 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 28,885 | $36.37 | $1,050,547.45 | -18.1% | |
| Jun 5, 2017 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sell | 4,311 | $43.32 | $186,756.83 | -6.7% | |
| Jan 17, 2017 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 15,000 | $38.41 | $576,122.00 | -19.0% | |
| Nov 15, 2016 | PCRX Pacira Biosciences, Inc. | CEO and Chairman | Sale+OE | 15,000 | $37.28 | $559,140.00 | -19.1% |